Sionna chooses Phase 2a cystic fibrosis drug after healthy volunteer study

Newly-public biotech Sionna Therapeutics is ready to head into mid-stage testing. In an update reporting healthy volunteer data for two cystic fibrosis drugs, Sionna said it will move SION-719 into a Phase …